Showing results (1621-1630 of 2,301) with videos related to
Sort By:
Pageof 231
Dalton Transactions (Cambridge, England : 2003)|October 4, 2018
A sulphur and uranium fiesta! Synthesis, structure, and characterization of neutral terminal uranium(vi) monosulphide, uranium(vi) η<sup>2</sup>-disulphide, and uranium(iv) phosphine sulphide complexesJustin K Pagano, David S J Arney, Brian L Scott, et al.Physical Review Letters|June 24, 2017
Nature of the Spin Liquid Ground State in a Breathing Kagome Compound Studied by NMR and Series ExpansionJ-C Orain, B Bernu, P Mendels, et al.Western Journal of Nursing Research|February 13, 2025
Health Professional Perceptions of Delivering Hospital Falls Prevention Education-A Qualitative StudyAnne-Marie Hill, Cheng Yen Loo, Steffanie Coulter, et al.JCO Oncology Practice|February 1, 2023
Early Bereavement Psychosocial Outcomes in Parents of Children Who Died of Cancer With a Focus on Social FunctioningJennifer M Snaman, Emanuele Mazzola, Gabrielle Helton, et al.International Immunopharmacology|April 12, 2003
Intravenous and oral pharmacokinetic study of BCX-1777, a novel purine nucleoside phosphorylase transition-state inhibitor. In vivo effects on blood 2'-deoxyguanosine in primatesJ Michael Kilpatrick, Philip E Morris, David G Serota, et al.European Radiology|February 24, 2019
Standardised reports with a template format are superior to free text reports: the case for rectal cancer reporting in clinical practiceP J Brown, H Rossington, J Taylor, et al.Atherosclerosis|November 29, 2011
Influence of matrix metalloproteinase-12 on fibrinogen levelAnna Motterle, Qingzhong Xiao, Stefan Kiechl, et al.BMC Pulmonary Medicine|February 21, 2012
A phase I study evaluating the pharmacokinetics, safety and tolerability of an antibody-based tissue factor antagonist in subjects with acute lung injury or acute respiratory distress syndromePeter E Morris, Jay S Steingrub, Bee Y Huang, et al.Critical Care (London, England)|February 21, 2012
A placebo-controlled, double-blind, dose-escalation study to assess the safety, tolerability and pharmacokinetics/pharmacodynamics of single and multiple intravenous infusions of AZD9773 in patients with severe sepsis and septic shockPeter E Morris, Brian Zeno, Andrew C Bernard, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 11, 2011
The orally bioavailable met inhibitor PF-2341066 inhibits osteosarcoma growth and osteolysis/matrix production in a xenograft modelErik R Sampson, Brad A Martin, Aimee E Morris, et al.Pageof 231